Foundry Partners, LLC Innoviva, Inc. Transaction History

Foundry Partners, LLC

  • $1.95 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 16, 2018
SELL
$13.8 - $16.99 $1.04 Million - $1.28 Million
-75,440 Closed
0 $0
Q4 2017

Jan 25, 2018
SELL
$11.73 - $14.75 $696,726 - $876,105
-59,397 Reduced 44.05%
75,440 $1.07 Million
Q3 2017

Oct 31, 2017
BUY
$12.06 - $14.12 $1.63 Million - $1.9 Million
134,837
134,837 $1.9 Million

Others Institutions Holding INVA

# of Institutions
229
Shares Held
79.2M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Foundry Partners, LLC Portfolio

Follow Foundry Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundry Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email